Iranian Journal of Veterinary Surgery

Iranian Journal of Veterinary Surgery

Protective Effects of Royal Jelly on Oxidative Stress and In Vitro Fertilization Outcomes in a Wistar Rat Model of Varicocele

Document Type : Original Article

Authors
Ghodrat Ebadimanas 1
Gholamreza Najafi 2
Ali Shalizar-Jalali 2
1 Department of Biology Education, Farhangian University, Tehran, Iran.
2 Department of Basic Sciences, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran.
10.30500/ivsa.2025.504161.1436
Abstract
Varicocele, characterized by the abnormal tortuosity and dilation of the pampiniform plexus veins in the spermatic cord, is the most common surgically correctable cause of male infertility. This study aimed to evaluate the protective effects of royal jelly on sperm parameters and in vitro fertilization (IVF) outcomes in a rat model of varicocele. Thirty adult male rats were randomly divided into five groups (n = 6): control, varicocele, varicocele with low-dose royal jelly (50 mg/kg), varicocele with medium-dose royal jelly (100 mg/kg), and varicocele with high-dose royal jelly (200 mg/kg). After a 28-day treatment period, malondialdehyde (MDA), total antioxidant capacity (TAC), sperm parameters, and IVF outcomes were assessed. The varicocele group showed significant reductions in TAC, sperm count, motility, viability, and embryonic development outcomes, including zygote formation, two-cell embryos, blastocysts, and hatched embryos, compared to the control group. Royal jelly treatment improved sperm parameters, fertilization rates, and embryo development in a dose-dependent manner. These findings suggest that royal jelly mitigates the adverse effects of varicocele on fertility in rat, likely due to its antioxidant and free radical scavenging properties.
Keywords
Varicocele
Royal jelly
Sperm parameters
IVF
Embryo development
Oxidative stress

Subjects

  1. Takács T, Szabó A, Kopa Z. Recent trends in the management of varicocele. Journal of Clinical Medicine. 2025; 14(15): 5445. doi: 10.3390/jcm14155445
  2. Naughton CK, Nangia AK, Agarwal A. Varicocele and male infertility: part II: pathophysiology of varicoceles in male infertility. Human Reproduction Update. 2001; 7(5): 473-481. doi: 10.1093/humupd/7.5.473
  3. Agarwal A, Majzoub A, Baskaran S, Sikka SC. Oxidation-reduction potential and its association with sperm quality and male infertility. Andrologia. 2019; 51(7): e13258. doi: 10.1111/and.13258
  4. Pasupuleti VR, Sammugam L, Ramesh N, Gan SH. Honey, propolis, and royal jelly: a comprehensive review of their biological actions and health benefits. Oxidative Medicine and Cellular Longevity. 2017; 2017(1): 1259510. doi: 10.1155/2017/1259510
  5. Silici S, Ekmekcioglu O, Eraslan G, Demirtas E. Antioxidative effect of royal jelly in cisplatin-induced testes damage. Urology. 2009; 74(3): 545-551. doi: 10.1016/j.urology.2009.05.024
  6. Turner TT. The study of varicocele through the use of animal models. Human Reproduction Update. 2001; 7(1): 78-84. doi: 10.1093/humupd/7.1.78
  7. Azad F, Nejati V, Shalizar-Jalali A, Najafi G, Rahmani F. Royal jelly protects male mice against nicotine-induced reproductive failure. Veterinary Research Forum. 2018; 9(3): 231-238. doi: 10.30466/vrf.2018.32088
  8. Babaei M, Najafi G, Jalali AS, Behfar M. Effects of unilateral iatrogenic vas deferens trauma on fertility: an experimental in vitro fertilization mice model study. Bulletin of Emergency and Trauma. 2015; 3(4): 122-127.
  9. Armand Z, Najafi G, Farokhi F, Jalali AS. Attenuation of cyclosporine-induced sperm impairment and embryotoxicity by Crataegus monogyna fruits aqueous extract. Cell Journal. 2013; 15(3): 198-205.
  10. Mahdivand N, Najafi G, Nejati V, Shalizar-Jalali A, Rahmani F. Royal jelly protects male rats from heat stress-induced reproductive failure. Andrologia. 2019; 51(3): e13213. doi: 10.1111/and.13213
  11. Aaly-Gharibeh Z, Hosseinchi M, Shalizar-Jalali A. Effect of nanocurcumin on fertility in murine model of polycystic ovary syndrome. Veterinary Research Forum. 2024; 15(2): 113-117. doi: 10.30466/vrf.2023.2006604.3935
  12. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as measure of "antioxidant power": the FRAP assay. Analytical Biochemistry. 1996; 239(1): 70-76. doi: 10.1006/abio.1996.0292
  13. Nistal M, González-Peramato P. Varicocele, the most common cause of treatable infertility. In: Testicular Vascular Lesions. Cham: Springer Nature Switzerland. 2024; 159-169.
  14. Asadi N, Kheradmand A, Gholami M, Saidi SH, Mirhadi SA. Effect of royal jelly on testicular antioxidant enzymes activity, MDA level and spermatogenesis in rat experimental varicocele model. Tissue and Cell. 2019; 57: 70-77. doi: 10.1016/j.tice.2019.02.005
  15. Kang C, Punjani N, Lee RK, Li PS, Goldstein M. Effect of varicoceles on spermatogenesis. Seminars in Cell and Developmental Biology. 2022; 121: 114-124. doi: 10.1016/j.semcdb.2021.04.005
  16. Majd NE, Sadeghi N, Tavalaee M, Tabandeh MR, Nasr-Esfahani MH. Evaluation of oxidative stress in testis and sperm of rat following induced varicocele. Urology Journal. 2019; 16(3): 300-306. doi: 10.22037/uj.v0i0.4740
  17. Cho C-L, Esteves SC, Agarwal A. Novel insights into the pathophysiology of varicocele and its association with reactive oxygen species and sperm DNA fragmentation. Asian Journal of Andrology. 2015; 18(2): 186–193. doi: 10.4103/1008-682X.170441
  18. Khodabandeh Z, Nejati V, Shalizar-Jalali A, Najafi G, Rahmani F. Effect of royal jelly on in vitro fertilization and early embryo development following nicotine treatment in adult female rats. Asian Pacific Journal of Reproduction. 2021; 10(3): 121-126. doi: 10.4103/2305-0500.316624
  19. Mahdivand N, Shalizar-Jalali A, Nejati V, Najafi G, Rahmani F. Adaptogenic potential of royal jelly in reproductive system of heat stress-exposed male rats. Journal of Thermal Biology. 2021; 96: 102827. doi: 10.1016/j.jtherbio.2020.102827
  20. Azad F, Nejati V, Shalizar-Jalali A, Najafi G, Rahmani F. Antioxidant and anti-apoptotic effects of royal jelly against nicotine-induced testicular injury in mice. Environmental Toxicology. 2019; 34(6): 708-718. doi: 10.1002/tox.22737

  • Receive Date 02 February 2025
  • Revise Date 22 April 2025
  • Accept Date 21 May 2025
  • First Publish Date 21 May 2025